Characteristic | Recurrence-free survival | Progression-free survival | ||||
---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||
p value | HR (95 % CI) | p value | p value | HR (95 % CI) | p value | |
Age | 0.133 | 0.775 | ||||
<70 years | ||||||
≥70 years | ||||||
Sex | 0.166 | 0.861 | ||||
Male | ||||||
Female | ||||||
Tumor grade | 0.916 | 0.289 | ||||
G1/2 | ||||||
G3 | ||||||
Concomitant CIS | 0.653 | 0.925 | ||||
Positive | ||||||
Negative | ||||||
Multifocality | 0.063 | 0.344 | ||||
Single | ||||||
Multiple | ||||||
BCG instillation | 0.005 | 0.007 | 0.953 | |||
Yes | 0.44 (0.24–0.80) | |||||
No | ||||||
Intravesical chemotherapy | 0.007 | 0.631 | ||||
Yes | ||||||
No | ||||||
History of Ta NMIBC | 0.735 | 0.245 | ||||
Recurrence | ||||||
Primary | ||||||
Lymphovascular invasion | 0.192 | 0.003 | 0.006 | |||
Positive | 4.00 (1.49–10.75) | |||||
Negative |